Shiba Life Sciences Private Limited

Shiba Life Sciences Private Limited

Distributes and markets a variety of healthcare products, including medicine, supplements, and cosmetics.
2004 | Lucknow, Uttar Pradesh (India) | Active

Last Updated:

July 07, 2024
HomeCompanyShiba Life Sciences Private Limited

Who are the key members and board of directors at Shiba Life Sciences?

Board Members(2)

NameDesignationAppointment DateStatus
Rajesh Singh In Additional Director 26-Nov-2008Current
Kusum Singh In Director 16-Apr-2007Current

Financial Performance of Shiba Life Sciences.

Shiba Life Sciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.66% decrease. The company also saw a substantial improvement in profitability, with a 135.02% increase in profit. The company's net worth Soared by an impressive increase of 307.32%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-7.66%
Revenue from Operations
-7.66%
Total Assets
11.64%
Profit or Loss
135.02%
Net Worth
307.32%
EBITDA
34.20%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹5.70 M

LenderAmountStatus

Others

Creation Date: 11 Aug 2021
₹0.40 MOpen

Canara Bank

Creation Date: 29 Dec 2009
₹5.30 MOpen

How Many Employees Work at Shiba Life Sciences?

Unlock and access historical data on people associated with Shiba Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Shiba Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Shiba Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Shiba Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.

    31 Mar 2023

  • Charges

    A charge with Canara Bank of Rs. 5.30 M registered on 29 Dec 2009 with Charge ID 10195742 was modified on 21 Nov 2022.

    21 Nov 2022

  • Charges

    A charge with Others amounted to Rs. 0.40 M with Charge ID 100496146 was registered on 11 Aug 2021.

    11 Aug 2021

  • Charges

    A charge with Canara Bank amounted to Rs. 5.30 M with Charge ID 10195742 was registered on 29 Dec 2009.

    29 Dec 2009

  • Director Appointment

    Rajesh Prasad Singh was appointed as a Additional Director was appointed as a Additional Director on 26 Nov 2008 & has been associated with this company since 16 years 28 days .

    26 Nov 2008

Frequently asked questions

  • Shiba Life Sciences Private Limited was incorporated on 16 Aug 2004.

  • The authorized share capital of Shiba Life Sciences Private Limited is ₹ 1.20 M and paid-up capital is ₹ 1.10 M.

  • Currently 2 directors are associated with Shiba Life Sciences Private Limited.

    • Rajesh Prasad Singh
    • Kusum Singh
  • As per Ministry of Corporate Affairs (Mca), the registered address of Shiba Life Sciences Private Limited is 2/115 Vikas Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India, 226010.

  • The corporate identification number (CIN) of Shiba Life Sciences Private Limited is U24232UP2004PTC028949 and the company number is 028949 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Shiba Life Sciences Private Limited has fallen by -7.66%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Shiba Life Sciences Private Limited has experienced an upsurge of 307.32%.

  • As per the financial statements for fiscal Year 2020, The total open charges for Shiba Life Sciences Private Limited amount to ₹ 5.70 M.

  • The most recent Balance Sheet for Shiba Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development